Over the last decade, the vast majority of men diagnosed with prostate cancer were found to have an early stage of the disease and no evidence that the cancer had spread to lymph nodes or other organs. Considerable research has focused on the best treatment strategy for these patients, who numbered an estimated 217,700 in 2010, and the Radiation Therapy Oncology Group (RTOG) has launched a new trial aimed at assessing quality of life outcomes in two hypofractionated radiotherapy (RT) regimens.

Source: RadiologyCombined analysis of 7T R2* and phase data may be able to distinguish between changes in tissue myelin and iron in multiple sclerosis (MS) patients, and could help in characterizing the disease process of MS lesions, according to a study published in the Nov. 14 issue of Radiology.

Source: RadiologyCT angiography (CTA) can accurately depict the presence and location of an active or recent hemorrhage in ED patients presenting with acute lower intestinal bleeding, and it should be considered as the preferred first step in diagnostic evaluation in such patients, according to a study published online Nov. 14 in Radiology.

As the Jan. 1, 2012 deadline to transition to HIPAA 5010 encroaches, those who are ill prepared for the change can breathe a sigh of reliefat least for two more months. On Nov. 17, the Centers for Medicare & Medicaid Services (CMS) Office of E-Health Standards and Services said it will not enforce action until March 31, 2012, which is good news for unprepared practices as not meeting this deadline could disrupt cash flow.

NDS Surgical Imaging (NDSsi) has received Health Canada approval for its ZeroWire wireless surgical video technology.

The American Hospital Association (AHA) has responded to a triumvirate of federal agencies proposed rule on patients access to test reports, warning them of unintended burdens that come with the proposed rule.

The 2011 American Heart Association's scientific sessions Nov. 12 to 16 in Orlando, Fla., and the 2011 Transcatheter Cardiovascular Therapeutics Nov. 7 to 11 event in San Francisco highlighted much evidence to inform practice, as well as opportunities for future research.

U.S. Sen. Al Franken (D-Minn.) proposed a bill Nov. 15 that aims to promote devices that treat rare diseases, ease conflict-of-interest regulations for approval committees and lift a profit cap on humanitarian use devices. The legislation would bring devices to market faster, he said.